Journal
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 35, Issue 1, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2021.101521
Keywords
Cushing's syndrome; Cushing's disease; mild autonomous cortisol secretion; incidence; prevalence; standardised mortality ratio (SMR)
Categories
Ask authors/readers for more resources
Endogenous Cushing's syndrome is a rare endocrine disorder characterized by excess cortisol secretion. Patients with active CS have elevated mortality rates, primarily due to cardiovascular disease. Early diagnosis, prompt treatment, and strict control of cardiovascular risk factors are crucial for the long-term prognosis of these patients.
Endogenous Cushing's syndrome (CS) is a rare endocrine disorder characterised by excess cortisol secretion due to either ACTH-dependent conditions [commonly an ACTH-producing pituitary adenoma (Cushing's disease)] or ACTH-independent causes (with most common aetiology being a benign adrenal adenoma). Overall, the annual incidence of CS ranges between 1.8 and 3.2 cases per million population. Mortality in active CS is elevated compared to the general population, and a number of studies support the view that survival is also compromised even after apparent successful treatment. The main cause of death is cardiovascular disease highlighting the negative impact of cortisol excess on cardiovascular risk factors. Early diagnosis and prompt treatment of the cortisol excess, as well as vigilant monitoring and stringent control of cardiovascular risk factors are key elements for the long-term prognosis of these patients. (C) 2021 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available